Ethic Inc’s Concentrix CNXC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
Sell
-6,789
Closed -$351K 1221
2025
Q2
$351K Buy
6,789
+2,718
+67% +$144K 0.01% 943
2025
Q1
$220K Buy
+4,071
New +$195K ﹤0.01% 1043
2024
Q4
Sell
-5,013
Closed -$332K 1170
2024
Q3
$332K Buy
5,013
+1,685
+51% +$113K 0.01% 855
2024
Q2
$211K Sell
3,328
-1,685
-34% -$101K ﹤0.01% 1015
2024
Q1
$332K Sell
5,013
-6,365
-56% -$517K 0.01% 854
2023
Q4
$1.12M Buy
11,378
+1,531
+16% +$133K 0.03% 505
2023
Q3
$789K Buy
9,847
+4,731
+92% +$371K 0.03% 543
2023
Q2
$413K Buy
5,116
+641
+14% +$59.9K 0.02% 707
2023
Q1
$544K Buy
4,475
+2,504
+127% +$340K 0.02% 627
2022
Q4
$262K Buy
+1,971
New +$240K 0.01% 757

Other funds holding CNXC

Ethic Inc's CNXC Position: Q3 2025 in Review

Ethic Inc sold out of Concentrix (CNXC) in Q3 2025, closing a stake of 6,789 shares — an estimated $351K sold.

Ethic Inc first reported a position in CNXC in Q4 2022 and held it in 10 quarters. The position peaked at $1.12M in Q4 2023. 347 funds tracked by Wall St. Rank hold CNXC as of Q3 2025.

  • Ethic Inc reported no remaining Concentrix position as of Q3 2025 after selling out during the quarter.
  • Ethic Inc sold 6,789 Concentrix shares in Q3 2025, an estimated $351K.
  • Ethic Inc first reported a position in Concentrix in Q4 2022 and held it in 10 quarters.
  • Ethic Inc's Concentrix position peaked at $1.12M in Q4 2023.
  • 347 funds tracked by Wall St. Rank held Concentrix as of Q3 2025.

Based on Ethic Inc's 13F filing for Q3 2025, filed 17 Oct 2025.